The Interaction between Herpes Simplex Virus and Human Immunodeficiency Virus

Herpes

Volumn 11, Issue SUPPL. 1, 2004, Pages

  Celum, Connie L ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Acquisition; Antiviral; Asymptomatic; Epidemiology; HIV; HSV; Interaction; Lesion; Management; Prevention; Risk; Shedding; Sti; Suppression; Tests; Therapy; Transmission

Indexed keywords

ACICLOVIR; ANTIVIRUS AGENT; CD4 ANTIGEN; PROTEIN ICP0; PROTEIN ICP4; PROTEIN VP16; REGULATOR PROTEIN; UNCLASSIFIED DRUG;

BEHAVIOR MODIFICATION; CLINICAL TRIAL; CONFERENCE PAPER; EPITHELIUM; GENITAL HERPES; HERPES SIMPLEX VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; INFECTION RISK; LYMPHOCYTE MIGRATION; META ANALYSIS; PATIENT COUNSELING; PRIORITY JOURNAL; RISK FACTOR; SEROLOGY; SUPERINFECTION; SYMPTOMATOLOGY; TARGET CELL; VIRUS LOAD; VIRUS REACTIVATION; VIRUS REPLICATION; VIRUS SHEDDING; VIRUS TRANSMISSION;

HERPES GENITALIS; HERPESVIRUS 2, HUMAN; HIV; HIV INFECTIONS; HUMANS; RISK FACTORS; SEROEPIDEMIOLOGIC STUDIES; SEROLOGIC TESTS; VIRAL LOAD;

HUMAN HERPESVIRUS 2; HUMAN IMMUNODEFICIENCY VIRUS; SIMPLEXVIRUS;

EID: 1942499496     PISSN: 09697667     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (50)

1. O'Farrell N. Targeted interventions required against genital ulcers in African countries worst affected by HIV infection. Bull World Health Organ 2001;79:569-577.
2. Fleming DT, McQuillan GM, Johnson RE, Nahmias AJ, Aral SO, Lee FK et al. Herpes simplex virus type 2 in the United States, 1976 to 1994. N Engl J Med 1997;337:1105-1111.
3. Corey L, Adams HG, Brown ZA, Holmes KK. Genital herpes simplex virus infections: clinical manifestations, course, and complications. Ann Intern Med 1983;98:958-972.
4. Chen CY, Ballard RC, Beck-Sague CM, Dangor Y, Radebe F, Schmid S et al. Human immunodeficiency virus infection and genital ulcer disease in South Africa: the herpetic connection. Sex Transm Dis 2000;27:21-29.
5. Behets FM, Andriamiadana J, Randrianasolo D, Randriamanga R, Rasamilalao D, Chen CY et al. Chancroid, primary syphilis, genital herpes, and lymphogranuloma venereum in Antananarivo, Madagascar. J Infect Dis 1999;180:1382-1385.
6. Morse SA, Trees DL, Htun Y, Radebe F, Orle KA, Dangor Y et al. Comparison of clinical diagnosis and standard laboratory and molecular methods for the diagnosis of genital ulcer disease in Lesotho: association with human immunodeficiency virus infection. J Infect Dis 1997;175:583-589.
7. Limpakarnjanarat K, Mastro TD, Saisorn S, Uthaivoravit W, Kaewkungwal J, Korattana S et al. HIV-1 and other sexually transmitted infections in a cohort of female sex workers in Chiang Rai, Thailand. Sex Transm Infect 1999;75:30-35.
8. Siegal FP, Lopez C, Hammer GS, Brown AE, Kornfeld SJ, Gold J et al. Severe acquired immunodeficiency in male homosexuals, manifested by chronic perianal ulcerative herpes simplex lesions. N Engl J Med 1981;305:1439-1444.
9. Koelle DM, Abbo H, Peck A, Ziegweid K, Corey L. Direct recovery of herpes simplex virus (HSV)-specific: T lymphocyte clones from recurrent genital HSV-2 lesions. J Infect Dis 1994;169:956-961.
10. Wald A, Link K. Risk of human immunodeficiency virus infection in herpes simplex virus type 2-seropositive persons: a meta-analysis. J Infect Dis 2002;185:45-52.
11. Mbizvo EM, Msuya Sia E, Stray-Pedersen B, Chirenje MZ, Munjoma M, Hussain A. Association of herpes simplex virus type 2 with the human immunodeficiency virus among urban women in Zimbabwe. Int J STD AIDS 2002;13:343-348.
12. Schacker T, Zeh J, Hu HL, Hill E, Corey L. Frequency of symptomatic and asymptomatic herpes simplex virus type 2 reactivations among human immunodeficiency virus-infected men. J Infect Dis 1998;178:1616-1622.
13. Krone MR, Wald A, Tabet SR, Paradise M, Corey L, Celum CL. Herpes simplex virus type 2 shedding in human immunodeficiency virus-negative men who have sex with men: frequency, patterns, and risk factors. Clin Infect Dis 2000;30:26-267.
14. Holmberg SD, Stewart JA, Gerber AR, Byers RH, Lee FK, O'Malley PM et al. Prior herpes simplex virus type 2 infection as a risk factor for HIV infection. JAMA 1988;259:1048-1050.
15. Keet IP, Lee FK, van Griensven GJ, Lange JM, Nahmias A, Coutinho RA. Herpes simplex virus type 2 and other genital ulcerative infections as a risk factor for HIV-1 acquisition. Genitourin Med 1990;66:330-333.
16. Kingsley LA, Armstrong J, Rahman A, Ho M, Rinaldo CR, Jr. No association between herpes simplex virus type-2 seropositivity or anogenital lesions and HIV seroconversion among homosexual men. J Acquir Immune Defic Syndr 1990;3:773-779.
17. Renzi C, Douglas JM, Foster M, Critchlow CW, Ashley-Morrow R, Buchbinder SP et al. Herpes simplex virus type 2 infection as a risk factor for human immunodeficiency acquisition in men who have sex with men. J Infect Dis 2003;187:19-25.
18. McFarland W, Gwanzura L, Bassett MT, Machekano R, Latif AS, Ley C et al. Prevalence and incidence of herpes simplex virus type 2 infection among male Zimbabwean factory workers. J Infect Dis 1999;180:1459-1465.
19. Kamali A, Nunn AJ, Mulder DW, Van Dyck E, Dobbins JG, Whitworth JA. Seroprevalence and incidence of genital ulcer infections in a rural Ugandan population. Sex Transm Infect 1999;75:98-102.
20. del Mar Pujades Rodriguez M, Obasi A, Mosha F, Todd J, Brown D, Changalucha J et al. Herpes simplex virus type 2 infection increases HIV incidence: a prospective study in rural Tanzania. AIDS 2002;16:451-462.
21. Reynolds SJ, Risbud AR, Shepherd ME, Zenilman JM, Brookmeyer RS, Kulkarni SV et al. Recent herpes simplex virus type 2 infection and the risk of HIV acquisition in Pune, India. XIV International AIDS Conference, Barcelona, Spain, 2002; Abstract MoOrC1012.
22. Reynolds SJ, Risbud AR, Shepherd ME, Zenilman JM, Brookmeyer RS, Paranjape RS et al. Recent herpes simplex virus type 2 infection and the risk of human immunodeficiency virus type 1 acquisition in India. J Infect Dis 2003;187:1513-1521.
23. Kucera LS, Leake E, Iyer N, Raben D, Myrvik QN. Human immunodeficiency virus type 1 (HIV-1) and herpes simplex virus type 2 (HSV-2) can coinfect and simultaneously replicate in the same human CD4+ cell: effect of coinfection on infectious HSV-2 and HIV-1 replication. AIDS Res Hum Retroviruses 1990;6:641-647.
24. Heng MC, Heng SY, Allen SG. Co-infection and synergy of human immunodeficiency virus-1 and herpes simplex virus-1. Lancet 1994;343:255-258.
25. Golden MP, Kim S, Hammer SM, Ladd EA, Schaffer PA, DeLuca N et al. Activation of human immunodeficiency virus by herpes simplex virus. J Infect Dis 1992;166:494-499.
26. Albrecht MA, DeLuca NA, Byrn RA, Schaffer PA, Hammer SM. The herpes simplex virus immediate-early protein, ICP4, is required to potentiate replication of human immunodeficiency virus in CD4+ lymphocytes. J Virol 1989;63:1861-1868.
27. Mosca JD, Bednarik DP, Raj NB, Rosen CA, Sodroski JG, Haseltine WA et al. Activation of human immunodeficiency virus by herpesvirus infection: identification of a region within the long terminal repeat that responds to a trans-acting factor encoded by herpes simplex virus 1. Proc Natl Acad Sci U S A 1987;84:7408-7412.
28. Cunningham AL, Turner RR, Miller AC, Para MF, Merigan TC. Evolution of recurrent herpes simplex lesions. An immunohistologic study. J Clin Invest 1985;75:226-233.
29. Fauci AS. The human immunodeficiency virus: infectivity and mechanisms of pathogenesis. Science 1988;239:617-622.
30. Mole L, Ripich S, Margolis D, Holodniy M. The impact of active herpes simplex virus infection on human immunodeficiency virus load. J Infect Dis 1997;176:766-770.
31. Schacker T, Zeh J, Hu H, Shaughnessy M, Corey L. Changes in plasma human immunodeficiency virus type 1 RNA associated with herpes simplex virus reactivation and suppression. J Infect Dis 2002;186:1718-1725.
32. Suligoi B, Dorrucci M, Volpi A, Andreoni M, Rezza G. No protective effect of acyclovir on HIV disease progression in a cohort of HSV-2-HIV-infected individuals. Antivir Ther 2002;7:289-291.
33. Gray RH, Wawer MJ, Brookmeyer R, Sewankambo NK, Serwadda D, Wabwire-Mangen F et al. Probability of HIV-1 transmission per coital act in monogamous, heterosexual, HIV-1-discordant couples in Rakai, Uganda. Lancet 2001;357:1149-1153.
34. Kreiss JK, Coombs R, Plummer F, Holmes KK, Nikora B, Cameron W et al. Isolation of human immunodeficiency virus from genital ulcers in Nairobi prostitutes. J Infect Dis 1989;160:380-384.
35. Schacker T, Ryncarz AJ, Goddard J, Diem K, Shaughnessy M, Corey L. Frequent recovery of HIV-1 from genital herpes simplex virus lesions in HIV-1-infected men. JAMA 1998;280:61-66.
36. Mbopi-Keou FX, Gresenguet G, Mayaud P, Weiss HA, Gopal R, Matta M et al. Interactions between herpes simplex virus type 2 and human immunodeficiency virus type 1 infection in African women: opportunities for intervention. J Infect Dis 2000;182:1090-1096.
37. Zhu T, Wang N, Carr A, Nam DS, Moor-Jankowski R, Cooper DA et al. Genetic characterization of human immunodeficiency virus type 1 in blood and genital secretions: evidence for viral compartmentalization and selection during sexual transmission. J Virol 1996;70:3098-3107.
38. Schacker T, Hu HL, Koelle DM, Zeh J, Saltzman R, Boon R et al. Famciclovir for the suppression of symptomatic and asymptomatic herpes simplex virus reactivation in HIV-infected persons. A double-blind, placebo-controlled trial. Ann Intern Med 1998;128:21-28.
39. Augenbraun M, Feldman J, Chirgwin K, Zenilman J, Clarke L, DeHovitz J et al. Increased genital shedding of herpes simplex virus type 2 in HIV-seropositive women. Ann Intern Med 1995;123:845-847.
40. Mostad SB, Kreiss JK, Ryncarz AJ, Mandaliya K, Chohan B, Ndinya-Achola J et al. Cervical shedding of herpes simplex virus in human immunodeficiency virus-infected women: effects of hormonal contraception, pregnancy, and vitamin A deficiency. J Infect Dis 2000;181:58-63.
41. McClelland RS, Wang CC, Overbaugh J, Richardson BA, Corey L, Ashley RL et al. Association between cervical shedding of herpes simplex virus and HIV-1. AIDS 2002;16:2425-2430.
42. Posavad CM, Koelle DM, Shaughnessy MF, Corey L. Severe genital herpes infections in HIV-infected individuals with impaired herpes simplex virus-specific CD8+ cytotoxic T lymphocyte responses. Proc Natl Acad Sci U S A 1997;94:10289-10294.
43. Palella FJ, Jr, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med 1998;338:853-860.
44. Cameron DW, Simonsen JN, D'Costa LJ, Ronald AR, Maitha GM, Gakinya MN et al. Female to male transmission of human immunodeficiency virus type 1: risk factors for seroconversion in men. Lancet 1989;2:403-407.
45. Dickerson MC, Johnston J, Delea TE, White A, Andrews E. The causal role for genital ulcer disease as a risk factor for transmission of human immunodeficiency virus. An application of the Bradford Hill criteria. Sex Transm Dis 1996;23:429-440.
46. Cohen MS, Hoffman IF, Royce RA, Kazembe P, Dyer JR, Daly CC et al. Reduction of concentration of HIV-1 in semen after treatment of urethritis: implications for prevention of sexual transmission of HIV-1. AIDSCAP Malawi Research Group. Lancet 1997;349:1868-1873.
47. Grosskurth H, Mosha F, Todd J, Mwijarubi E, Klokke A, Senkoro K et al. Impact of improved treatment of sexually transmitted diseases on HIV infection in rural Tanzania: randomised controlled trial. Lancet 1995;346:530-536.
48. Wawer MJ, Sewankambo NK, Serwadda D, Quinn TC, Paxton LA, Kiwanuka N et al. Control of sexually transmitted diseases for AIDS prevention in Uganda: a randomised community trial. Rakai Project Study Group. Lancet 1999;353:525-535.
49. Grosskurth H, Gray R, Hayes R, Mabey D, Wawer M. Control of sexually transmitted diseases for HIV-1 prevention: understanding the implications of the Mwanza and Rakai trials. Lancet 2000;355:1981-1987.
50. Ballard RC. Syndromic case management of STDs in Africa. Afr Health 1998;20:13-15.